The story of a husband
and wife who traveled from Melbourne, Australia for treatment
of Alzheimer's disease utilizing the unique perispinal etanercept
treatment invented at the Institute for Neurological Research®
(INR®) in Los Angeles. Before and after video, testing, and
interview with the patient's wife. Please see
Perispinal etanercept
for neuroinflammatory disorders.
Edward Tobinick MD. Drug
Discovery Today 2009 Feb; 14(3-4):168-77.The videos above are interviews discussing
and documenting the clinical response to initiation of anti-TNF
treatment (perispinal etanercept) at the INR. For the published
results please see Tobinick E, Gross H, Weinberger A, Cohen H.,
TNF-alpha Modulation for Treatment of Alzheimer's Disease:
A 6-Month Pilot Study MedGenMed 2006; 8(2) :25; Tobinick
E., Perispinal etanercept for treatment of Alzheimer's disease,
Current Alzheimer Research 2007 Dec; 4(5):550-2; Tobinick
E, Gross H., Rapid improvement in verbal fluency and aphasia
following perispinal etanercept in Alzheimer's disease, BMC
Neurology 2008; 8:27; and Tobinick E., Perispinal etanercept
for neuroinflammatory disorders, Drug Discovery Today
2009 Feb; 14(3-4):168-77.Institute for Neurological Research, a private medical group, inc.
100 UCLA Medical Plaza, Suites 205-210 Los Angeles, California
90095
Video2